What is the role of rheumatologists in the era of COVID-19?
作者信息
Marotto Daniela, Sarzi-Puttini Piercarlo
机构信息
Rheumatology Unit, ATS Sardegna, P. Dettori Hospital, Tempio Pausania, Italy.
Rheumatology Unit, ASST-Fatebenefratelli L, Sacco University Hospital, University of Milan, Italy.
出版信息
Autoimmun Rev. 2020 Jun;19(6):102539. doi: 10.1016/j.autrev.2020.102539. Epub 2020 Apr 3.
Abstract
摘要
相似文献
1
What is the role of rheumatologists in the era of COVID-19?
Autoimmun Rev. 2020 Jun;19(6):102539. doi: 10.1016/j.autrev.2020.102539. Epub 2020 Apr 3.
2
COVID-19: an unexpected indication for anti-rheumatic therapies?
Rheumatology (Oxford). 2020 Jun 1;59(6):1200-1203. doi: 10.1093/rheumatology/keaa194.
3
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy.
J Autoimmun. 2020 May;109:102442. doi: 10.1016/j.jaut.2020.102442. Epub 2020 Apr 2.
4
Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
Indian Heart J. 2020 Mar-Apr;72(2):131-132. doi: 10.1016/j.ihj.2020.04.006. Epub 2020 Apr 27.
5
Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab.
Infection. 2020 Oct;48(5):767-771. doi: 10.1007/s15010-020-01476-7. Epub 2020 Jul 8.
6
Regulators split on antimalarials for COVID-19.
Lancet. 2020 Apr 11;395(10231):1179. doi: 10.1016/S0140-6736(20)30817-5.
7
Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials.
Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008688. doi: 10.1161/CIRCEP.120.008688. Epub 2020 May 21.
8
COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits.
Am J Crit Care. 2020 Nov 1;29(6):489-492. doi: 10.4037/ajcc2020694.
9
Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?
Med Hypotheses. 2020 Jul;140:109756. doi: 10.1016/j.mehy.2020.109756. Epub 2020 Apr 22.
10
Rheumotologitsts' view on the use of hydroxychloroquine to treat COVID-19.
Emerg Microbes Infect. 2020 Dec;9(1):830-832. doi: 10.1080/22221751.2020.1760145.
引用本文的文献
1
Prospects of Novel and Repurposed Immunomodulatory Drugs against Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 Disease.
J Pers Med. 2023 Apr 13;13(4):664. doi: 10.3390/jpm13040664.
2
The radiological findings of COVID-19.
Turk J Med Sci. 2021 Dec 17;51(SI-1):3328-3339. doi: 10.3906/sag-2106-203.
3
Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2.
J Control Release. 2021 Sep 10;337:258-284. doi: 10.1016/j.jconrel.2021.07.028. Epub 2021 Jul 20.
4
The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19.
Front Pharmacol. 2021 May 6;12:584940. doi: 10.3389/fphar.2021.584940. eCollection 2021.
5
COVID-19 infection and rheumatoid arthritis: mutual outburst cytokines and remedies.
Curr Med Res Opin. 2021 Jun;37(6):929-938. doi: 10.1080/03007995.2021.1906637. Epub 2021 Apr 8.
6
Diabetes mellitus as a comorbidity in COVID-19 infection in the United Arab Emirates.
Saudi Med J. 2021 Feb;42(2):170-180. doi: 10.15537/smj.2021.2.25700.
7
The Rheumatologist's Role in the Battle Against COVID-19: Insights from the Front Line and Challenges for the Future.
Mediterr J Rheumatol. 2020 Sep 21;31(Suppl 2):247-252. doi: 10.31138/mjr.31.3.247. eCollection 2020 Sep.
8
Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study.
J Autoimmun. 2021 Jan;116:102545. doi: 10.1016/j.jaut.2020.102545. Epub 2020 Sep 22.
9
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
Clin Rheumatol. 2020 Nov;39(11):3195-3204. doi: 10.1007/s10067-020-05334-7. Epub 2020 Aug 27.
10
Rheumatologists' practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt.
Rheumatol Int. 2020 Oct;40(10):1599-1611. doi: 10.1007/s00296-020-04655-9. Epub 2020 Jul 24.
本文引用的文献
1
A human monoclonal antibody blocking SARS-CoV-2 infection.
Nat Commun. 2020 May 4;11(1):2251. doi: 10.1038/s41467-020-16256-y.
2
Effective treatment of severe COVID-19 patients with tocilizumab.
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29.
3
Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?
Autoimmun Rev. 2020 May;19(5):102524. doi: 10.1016/j.autrev.2020.102524. Epub 2020 Mar 24.
4
Applying the Lessons of Influenza to COVID-19 During a Time of Uncertainty.
Circulation. 2020 May 26;141(21):1667-1669. doi: 10.1161/CIRCULATIONAHA.120.046837. Epub 2020 Mar 25.
5
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.
JAMA. 2020 May 19;323(19):1897-1898. doi: 10.1001/jama.2020.4742.
6
Novel 2019 coronavirus SARS-CoV-2 (COVID-19): An updated overview for emergency clinicians.
Emerg Med Pract. 2020 May 1;22(5):1-28. Epub 2020 Mar 24.
7
COVID-19: the new challenge for rheumatologists.
Clin Exp Rheumatol. 2020 Mar-Apr;38(2):175-180. doi: 10.55563/clinexprheumatol/r3k9l6. Epub 2020 Mar 24.
8
COVID-19 infection and rheumatoid arthritis: Faraway, so close!
Autoimmun Rev. 2020 May;19(5):102523. doi: 10.1016/j.autrev.2020.102523. Epub 2020 Mar 20.
9
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
Clin Exp Rheumatol. 2020 Mar-Apr;38(2):337-342. doi: 10.55563/clinexprheumatol/xcdary. Epub 2020 Mar 22.
10
Of chloroquine and COVID-19.
Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5.
Zotero 插件